You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 38 No. 9, September 1981 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Positron Imaging in Ischemic Stroke Disease Using Compounds Labeled With Oxygen 15

Initial Results of Clinicophysiologic Correlations

Robert H. Ackerman, MD, MPH; John A. Correia, PhD; Nathaniel M. Alpert, PhD; Jean-Claude Baron, MD; Athanassios Gouliamos, MD; James C. Grotta, MD; Gordon L. Brownell, PhD; Juan M. Taveras, MD

Arch Neurol. 1981;38(9):537-543.


Abstract

• Initial results in over 50 patients with stroke suggest that positron images made during continuous inhalation of carbon dioxide labeled with oxygen 15 and molecular oxygen labeled with oxygen 15 provide data on tissue function that may be relevant to acute stroke management. Five cases illustrate the following findings:15O-activity patterns observed in areas of ischemic injury or infarction are what one would expect if the15O distributions represented physiologic functions, such as cerebral blood flow and metabolism. Areas of abnormal15O activity correlate with the clinical or computed tomographic (CT) localization of the deficit. In studies performed acutely, changes in15O distributions anticipate alterations in CT scans and may be predictive of outcome. Data related to oxygen metabolism correlate better with tissue viability than do those reflecting cerebral blood flow.



Author Affiliations

From the Cerebral Blood Flow Laboratory, the Department of Radiology (Drs Ackerman, Correia, Alpert, Baron, Gouliamos, Grotta, Brownell, and Taveras), and the Neurology Service (Drs Ackerman, Baron, and Grotta), Massachusetts General Hospital; and the Departments of Radiology and Neurology, Harvard Medical School, Boston. Dr Baron is now with HÔpital d'Orsay, France; Dr Gouliamos, the University "Aretaieion" Hospital, Athens, Greece; and Dr Grotta, the University of Texas Health Science Center, Houston.


Footnotes

Accepted for publication Dec 22, 1980.

Presented in part at the ninth International Symposium on Cerebral Blood Flow and Metabolism, Tokyo, June 1, 1979.

Reprint requests to Massachusetts General Hospital, Boston, MA 02114 (Dr Ackerman).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tissue Viability Thresholds in Acute Stroke: The 4-Factor Model
Warach
Stroke 2001;32:2460-2461.
FULL TEXT  

Acute Stroke Therapy at the Millennium: Consummating the Marriage Between the Laboratory and Bedside : The Feinberg Lecture
Grotta
Stroke 1999;30:1722-1728.
FULL TEXT  

Effect of Intracarotid Administration of 6-Aminonicotinamide on Cerebral Blood Flow in Cats
Kuchiwaki et al.
Stroke 1995;26:473-479.
ABSTRACT | FULL TEXT  

Positron emission tomography: human brain function and biochemistry
Phelps and Mazziotta
Science 1985;228:799-809.
ABSTRACT  

Barbiturate-enhanced detection of brain lesions by carbon-14-labeled 2-deoxyglucose autoradiography
Frey and Agranoff
Science 1983;219:879-881.
ABSTRACT  

Positron Tomography and Nuclear Magnetic Resonance Imaging
Brownell et al.
Science 1982;215:619-626.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.